Oral Epinephrine Film For Anaphylaxis Market Report 2026

Oral Epinephrine Film For Anaphylaxis Market Overview

• Oral Epinephrine Film For Anaphylaxis market size has reached to $0.51 billion in 2025 • Expected to grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 20.2% • Growth Driver: Rising Prevalence of Severe Allergies Driving The Market Growth Due To Increasing Demand for Fast-Acting Emergency Treatments • Market Trend: Regulatory Advancements In Sublingual Epinephrine Film Technology Support Innovation In Anaphylaxis Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oral Epinephrine Film For Anaphylaxis Market?

Oral epinephrine film for anaphylaxis is a fast-dissolving thin film medication designed to deliver epinephrine through the oral mucosa for the emergency treatment of severe allergic reactions. It provides a needle-free alternative to traditional epinephrine auto-injectors and is intended for rapid absorption and quick onset of action. The film is portable, easy to administer, and aims to improve convenience and accessibility during anaphylactic emergencies. The main product types of oral epinephrine film for anaphylaxis include orally dissolving film, injectable epinephrine, and nasal epinephrine. Orally dissolving film refers to a fast-dissolving dosage form designed to deliver epinephrine through the oral mucosa for rapid action during anaphylactic emergencies. These products are available in dosage strengths including high dose formulations, low dose formulations, and standard dose formulations and are suitable for age groups such as geriatric, pediatric, and adult. They are used for applications including insect sting allergic reactions, food allergy induced anaphylaxis, drug induced anaphylaxis, and others, and are utilized by end users such as retail pharmacies, school and institutional settings, hospital emergency departments, and home use.

What Is The Oral Epinephrine Film For Anaphylaxis Market Growth Forecast?

The oral epinephrine film for anaphylaxis market size is expected to see exponential growth in the next few years. It will grow to $1.27 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to expansion of needle free drug delivery technologies, increasing demand for patient friendly emergency allergy treatments, rising adoption of home based emergency care solutions, advancement in fast dissolving oral drug film technologies, growing regulatory support for alternative epinephrine delivery systems. Major trends in the forecast period include development of needle free oral epinephrine delivery systems for rapid anaphylaxis response, rising adoption of fast dissolving buccal and sublingual film drug formats, expansion of portable emergency allergy treatment solutions for home and public use, increasing focus on pediatric friendly and non invasive anaphylaxis therapies, advancements in polymer based drug film technology for faster mucosal absorption.

Global Oral Epinephrine Film For Anaphylaxis Market Segmentation

1) By Product Type: Orally Dissolving Film, Injectable Epinephrine, Nasal Epinephrine 2) By Dosage Strength: High Dose Formulations, Low Dose Formulations, Standard Dose Formulations 3) By Age Group: Geriatric, Pediatric, Adult 4) By Application: Insect Sting Allergic Reactions, Food Allergy Induced Anaphylaxis, Drug Induced Anaphylaxis, Other Applications 5) By End User: Retail Pharmacies, School And Institutional Settings, Hospital Emergency Departments, Home Use Subsegments: 1) By Orally Dissolving Film: Buccal Dissolving Films, Sublingual Dissolving Films, Fast Dissolving Oral Films, Polymer Based Oral Films, Single Dose Oral Films 2) By Injectable Epinephrine: Auto Injector Epinephrine, Prefilled Epinephrine Syringes, Manual Epinephrine Injection Devices, Disposable Epinephrine Injectors, Multi Dose Epinephrine Injectors 3) By Nasal Epinephrine: Single Spray Nasal Epinephrine, Metered Dose Nasal Sprays, Powder Based Nasal Epinephrine, Liquid Nasal Epinephrine, Pediatric Nasal Epinephrine

What Are The Drivers Of The Oral Epinephrine Film For Anaphylaxis Market?

The rising prevalence of severe allergies is expected to propel the growth of the oral epinephrine film for anaphylaxis market going forward. Severe allergies are hypersensitive immune responses to specific triggers such as food, insect venom, or medications that can rapidly escalate into life-threatening anaphylactic reactions. The increasing prevalence of severe allergies is largely driven by the rising incidence of food allergies, as greater exposure to allergenic foods combined with changes in dietary habits and environmental factors has significantly expanded the at-risk population susceptible to anaphylactic episodes. The growing number of individuals at risk for severe allergic reactions increases the need for accessible, portable, and easy-to-administer emergency epinephrine options that can be used promptly before medical help arrives. For instance, in April 2024, according to Food Allergy Research & Education (FARE), a US-based nonprofit organization, around 33 million people in the United States have at least one food allergy, including about 27 million adults, which means roughly 11% of adults are affected. Therefore, the rising prevalence of severe allergies is driving the growth of the oral epinephrine film for anaphylaxis industry. The increasing research and clinical development activities are expected to propel the growth of the oral epinephrine film for anaphylaxis market going forward. Research and clinical development activities refer to scientific investigations and structured trials conducted to discover, evaluate, and advance new therapeutic formulations from early-stage concept to regulatory approval. Research and clinical development activities are rising due to the growing demand for advanced and effective therapies for complex diseases, prompting pharmaceutical and biotechnology companies to accelerate innovation and expand clinical programs for faster regulatory approvals. The surge in active clinical programs directly expands the pipeline of orally delivered epinephrine candidates, generating regulatory submissions and accelerating the commercialization of novel film-based formats for anaphylaxis management. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry, a UK-based trade association, the count of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, increasing research and clinical development activities are driving the growth of the oral epinephrine film for anaphylaxis industry.

Key Players In The Global Oral Epinephrine Film For Anaphylaxis Market

Major companies operating in the oral epinephrine film for anaphylaxis market are Aquestive Therapeutics

Global Oral Epinephrine Film For Anaphylaxis Market Trends and Insights

Major companies operating in the oral epinephrine film for anaphylaxis market are focusing on advancing regulatory and clinical development activities for sublingual epinephrine films to improve emergency allergy treatment accessibility, portability, and ease of administration. Sublingual epinephrine film refers to a thin oral film formulation placed under the tongue for rapid absorption of epinephrine during severe allergic reactions, including anaphylaxis. For instance, in January 2026, Aquestive Therapeutics Inc., a U.S.-based pharmaceutical company, announced a regulatory development update for Anaphylm (dibutepinephrine) sublingual film following an ongoing review of its New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA). The company highlighted continued progress toward global regulatory expansion in Canada, Europe, and the United Kingdom, while positioning Anaphylm as a fast-acting, easy-to-use, and highly portable oral epinephrine product candidate designed for the treatment of severe allergic reactions, including anaphylaxis.

Regional Outlook

North America was the largest region in the oral epinephrine film for anaphylaxis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Epinephrine Film For Anaphylaxis Market?

The oral epinephrine film for anaphylaxis market consists of sales of sublingual epinephrine films, polymer matrix-based epinephrine films, and needle-free oral epinephrine delivery products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oral Epinephrine Film For Anaphylaxis Market Report 2026?

The oral epinephrine film for anaphylaxis market research report is one of a series of new reports from The Business Research Company that provides oral epinephrine film for anaphylaxis market statistics, including oral epinephrine film for anaphylaxis industry global market size, regional shares, competitors with a oral epinephrine film for anaphylaxis market share, detailed oral epinephrine film for anaphylaxis market segments, market trends and opportunities, and any further data you may need to thrive in the oral epinephrine film for anaphylaxis industry. This oral epinephrine film for anaphylaxis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.